NovelStem International Corp. Files 2023 Annual Report on Form 10-K

TL;DR

<b>NovelStem International Corp. has filed its 2023 annual report (10-K), detailing its financial performance and corporate information.</b>

AI Summary

NovelStem International Corp. (NSTM) filed a Annual Report (10-K) with the SEC on April 1, 2024. NovelStem International Corp. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company was formerly known as HOLLYWOOD MEDIA CORP and HOLLYWOOD COM INC. The company's principal business address is located at 2255 GLADES RD, STE 237 W, BOCA RATON, FL 33431. The filing covers the period from January 1, 2023, to December 31, 2023. The company is incorporated in Florida.

Why It Matters

For investors and stakeholders tracking NovelStem International Corp., this filing contains several important signals. This 10-K filing provides a comprehensive overview of NovelStem's financial health and operational status for the fiscal year 2023, which is crucial for investors to assess the company's performance and future prospects. Understanding the company's historical name changes and current corporate structure is important for accurate tracking and analysis of its business evolution and market position.

Risk Assessment

Risk Level: low — NovelStem International Corp. shows low risk based on this filing. The filing is a standard annual report (10-K) with no immediate red flags or significant negative financial disclosures evident in the provided header information.

Analyst Insight

Review the detailed financial statements and management discussion within the full 10-K filing to understand NovelStem's performance and strategic direction.

Key Numbers

• 2023-12-31 — Fiscal Year End (Period of report)
• 2024-04-01 — Filing Date (Date filed)
• 2023-01-01 — Reporting Period Start (Fiscal year start date)
• 2022-12-31 — Prior Year End (Comparison point for financial data)

Key Players & Entities

• NovelStem International Corp. (company) — Filer name
• HOLLYWOOD MEDIA CORP (company) — Former company name
• HOLLYWOOD COM INC (company) — Former company name
• BOCA RATON (location) — Business address city
• FL (location) — Business address state

FAQ

Industry Context

NovelStem International Corp. operates within the retail sector, specifically retail stores, NEC (5990). This filing provides insights into its performance within this industry.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to disclose material information to the public.

What Investors Should Do

1. Analyze the full 10-K for detailed financial performance metrics for FY 2023.
2. Investigate the company's business operations and any strategic initiatives mentioned in the report.
3. Compare current year financials with prior year data to identify trends and changes.

Key Dates

• 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K.
• 2024-04-01: Filing Date — Date the 10-K was officially filed with the SEC.

Year-Over-Year Comparison

This is the initial filing analyzed, so no comparison to a previous filing is available from the provided data.

Key Financial Figures

• $0.01 — ) of the Act: Common Stock, par value $0.01 per share (Title of Class) Indicate
• $6,875 — distributions of earnings from NetCo of $6,875 and $12,591, respectively, for the fisc
• $12,591 — ns of earnings from NetCo of $6,875 and $12,591, respectively, for the fiscal years end
• $2 million — inal seed investor in NewStem providing $2 million in July 2018 and another $2 million ove

Filing Documents

• form10-k.htm (10-K) — 1837KB
• ex10-10.htm (EX-10.10) — 5KB
• ex10-11.htm (EX-10.11) — 1KB
• ex10-12.htm (EX-10.12) — 1KB
• ex10-13.htm (EX-10.13) — 19KB
• ex10-14.htm (EX-10.14) — 19KB
• ex10-15.htm (EX-10.15) — 7KB
• ex10-16.htm (EX-10.16) — 7KB
• form10-k_001.jpg (GRAPHIC) — 8KB
• ex10-10_001.jpg (GRAPHIC) — 334KB
• ex10-10_002.jpg (GRAPHIC) — 319KB
• ex10-10_003.jpg (GRAPHIC) — 330KB
• ex10-10_004.jpg (GRAPHIC) — 335KB
• ex10-10_005.jpg (GRAPHIC) — 355KB
• ex10-10_006.jpg (GRAPHIC) — 295KB
• ex10-10_007.jpg (GRAPHIC) — 34KB
• ex10-11_001.jpg (GRAPHIC) — 321KB
• ex10-12_001.jpg (GRAPHIC) — 342KB
• 0001493152-24-012323.txt (&nbsp;) — 11702KB
• nstm-20231231.xsd (EX-101.SCH) — 46KB
• nstm-20231231_cal.xml (EX-101.CAL) — 62KB
• nstm-20231231_def.xml (EX-101.DEF) — 355KB
• nstm-20231231_lab.xml (EX-101.LAB) — 374KB
• nstm-20231231_pre.xml (EX-101.PRE) — 392KB
• form10-k_htm.xml (XML) — 1296KB

BUSINESS

BUSINESS 3 Item 1A. RISK FACTORS 8 Item 1B. UNRESOLVED STAFF COMMENTS 12 Item 2.

PROPERTIES

PROPERTIES 12 Item 3. LEGAL PROCEEDINGS 12 Item 4. MINE SAFETY DISCLOSURES 12 PART II Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 13 Item 6. [RESERVED] 13 Item 7. MANAGEMEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 14 Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 17 Item 8. FINANCIAL 17 Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 17 Item 9A. CONTROLS AND PROCEDURES 18 Item 9B. OTHER INFORMATION 18 Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 18 PART III Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 19 Item 11. EXECUTIVE COMPENSATION 21 Item 12. SECURITY 24 Item 13. CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE 25 Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 26 PART IV Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 27 Item 16. FORM 10-K SUMMARY 29 Certain such as "believes", "expects", "may", "will", "should" or "anticipates", or the negatives thereof, or comparable terminology, or by discussions of strategy. You are cautioned that our business and operations are subject to a variety of risks and uncertainties and, consequently, our actual results may materially differ from those projected by any forward-looking statements. Certain of such risks and uncertainties are discussed below under the heading "Item 1A. Risk Factors." 2 PART I Item 1. Business. NovelStem International Corp. ("NovelStem" or the "Company") is a development stage biotechnology holding company

– Legal Proceedings for information concerning proceedings related to NetCo

Item 3 – Legal Proceedings for information concerning proceedings related to NetCo. Employees We do not currently have any employees; however, the Company relies on consultants to perform the duties that would be performed by employees. Additional Financial Information For additional financial information regarding our operations, see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" and our Financial Statements included in this Annual Report. Available Information We file annual, quarterly and current reports and other information with the U.S. Securities and Exchange Commission (the "SEC"). These filings are available to the public over the internet at the SEC's website at http://www.sec.gov. You may also read and copy any document we file at the SEC's public reference room located at 100 F Street, NE, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our website can be found at http://novelstem.com. 7 Item 1A. Risk Factors. Our business is subject to certain risks, including those described below. If any of the events described in the following risk factors actually occurs then our business, results of operations and financial condition could be materially adversely affected. More detailed information concerning these risks is contained in other sections of this registration statement, including "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Risks Relating to our Business We are a holding company the principal assets of which are illiquid, ownership interests in NewStem and NetCo. Our Company's primary assets are equity interests in NewStem and NetCo. Our President and Executive Chairman, Jan Loeb, is also the Chairman of NewStem and through this shared management structure along with our 30.51% ownership interest in NewStem, we are able to exert significant influence over

View Full Filing

View this 10-K filing on SEC EDGAR